A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

NCT07030712 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Neoplasm

Interventions

DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
DRUG: MK-8294
OTHER: CD8 PET Tracer

Sponsor

Merck Sharp & Dohme LLC